Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 09 tags : Biopharma save search
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
Published: 2022-05-09 (Crawled : 21:00) - sutrobio.com
STRO | $3.47 -6.72% -7.2% 730K
|
Health Technology
|
| O: 4.57%
H: 5.99%
C: 1.33%
biopharma
RedHill Biopharma Announces $15 Million Registered Direct Offering with a Leading Healthcare Investor
Published: 2022-05-09 (Crawled : 13:20) - biospace.com/
RDHL | $0.4199 -1.85% -3.08% 190K
|
Health Technology
|
| O: -13.84%
H: 4.37%
C: -21.17%
offering biopharma
Mereo BioPharma announces Positive Top-Line Efficacy and Safety Data from “ASTRAEUS” Phase 2 Trial of Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Emphysema
Published: 2022-05-09 (Crawled : 12:00) - biospace.com/
MREO | $2.78 0.18% 750K
|
Health Technology
|
| O: 1.77%
H: 0.97%
C: -31.05%
biopharma trial positive topline phase 2 alvelestat
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.